- Home
- MDGL vs OBDC Comparison
MDGL vs OBDC Comparison
Compare MDGL & OBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- OBDC
- Stock Information
- Founded
- MDGL 2011
- OBDC 2015
- Country
- MDGL United States
- OBDC United States
- Employees
- MDGL N/A
- OBDC N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- OBDC Investment Managers
- Sector
- MDGL Health Care
- OBDC Finance
- Exchange
- MDGL Nasdaq
- OBDC Nasdaq
- Market Cap
- MDGL 6.0B
- OBDC 5.8B
- IPO Year
- MDGL N/A
- OBDC 2019
- Fundamental
- Price
- MDGL $210.47
- OBDC $15.13
- Analyst Decision
- MDGL Buy
- OBDC Buy
- Analyst Count
- MDGL 14
- OBDC 7
- Target Price
- MDGL $343.83
- OBDC $15.83
- AVG Volume (30 Days)
- MDGL 287.0K
- OBDC 1.8M
- Earning Date
- MDGL 11-04-2024
- OBDC 11-06-2024
- Dividend Yield
- MDGL N/A
- OBDC 10.12%
- EPS Growth
- MDGL N/A
- OBDC N/A
- EPS
- MDGL N/A
- OBDC 1.79
- Revenue
- MDGL $14,638,000.00
- OBDC $1,606,586,000.00
- Revenue This Year
- MDGL N/A
- OBDC $2.90
- Revenue Next Year
- MDGL $269.77
- OBDC $6.63
- P/E Ratio
- MDGL N/A
- OBDC $8.44
- Revenue Growth
- MDGL N/A
- OBDC 11.85
- 52 Week Low
- MDGL $119.76
- OBDC $12.99
- 52 Week High
- MDGL $299.98
- OBDC $16.91
- Technical
- Relative Strength Index (RSI)
- MDGL 37.55
- OBDC 60.75
- Support Level
- MDGL $204.67
- OBDC $14.76
- Resistance Level
- MDGL $218.55
- OBDC $15.23
- Average True Range (ATR)
- MDGL 7.06
- OBDC 0.17
- MACD
- MDGL 1.41
- OBDC 0.05
- Stochastic Oscillator
- MDGL 35.23
- OBDC 88.76
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About OBDC Blue Owl Capital Corporation
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.